SHARE PURCHASE AGREEMENT dated as of June 29, 2018 by and among ATHENEX, INC., and PERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.Share Purchase Agreement • July 2nd, 2018 • Athenex, Inc. • Pharmaceutical preparations • New York
THIS SHARE PURCHASE AGREEMENT, dated as of June 29, 2018 (this “Agreement”), is made by and between Athenex, Inc., a company incorporated under the laws of the State of Delaware (the “Company”) and Perceptive Life Sciences Master Fund, Ltd., a Cayman Islands exempted company (the “Investor”).
CREDIT AGREEMENT AND GUARANTY dated as of June 30, 2018 by and among ATHENEX, INC., as the Borrower, THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO as the Lenders, and PERCEPTIVE...Credit Agreement and Guaranty • July 2nd, 2018 • Athenex, Inc. • Pharmaceutical preparations • New York
CREDIT AGREEMENT AND GUARANTY, dated as of June 30, 2018 (this “Agreement”), among ATHENEX, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to provide Guarantees from time to time hereunder (each a “Guarantor” and collectively, the “Guarantors”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).
LICENSE AND SUPPLY AGREEMENT by and between ATHENEX THERAPEUTICS LIMITED and AVALON HEPAPOC LIMITED GALACTOSE METER AND STRIPLicense and Supply Agreement • July 2nd, 2018 • Athenex, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into as of June 29, 2018 (“Effective Date”), by and between ATHENEX THERAPEUTICS LIMITED, a company incorporated in Hong Kong having a registered address at Unit 608-613 IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong (“Athenex”) and AVALON HEPAPOC LIMITED, a company existing under the laws of Hong Kong and having a registered address at 10/F, Fung House, 19-20 Connaught Road Central, Hong Kong (“Avalon”).
LICENSE AGREEMENT by and between XIANGXUE LIFE SCIENCES LTD. and AXIS THERAPEUTICS LIMITED June 29, 2018License Agreement • July 2nd, 2018 • Athenex, Inc. • Pharmaceutical preparations • Hong Kong
THIS LICENSE AGREEMENT (this “Agreement”) is made as of June 29, 2018 (the “Effective Date”), by and between Xiangxue Life Sciences Ltd., a company organized and existing under the laws of the People’s Republic of China and having its principal office at 2 Jinfengyuan Road, Guangzhou, China (“Licensor” or “XLifeSc”) and Axis Therapeutics Limited, a company organized and existing under the laws of Hong Kong and having its principal office at Unit 608-613 IC Development Centre, No 6 Science Park West Avenue, Science Park, Hong Kong (“Licensee” and together with Licensor, the “Parties” and each individually, a “Party”) and, solely for the purposes of SECTION 4.1, Athenex, Inc. (“Athenex”).
LICENSE AGREEMENT by and between ATHENEX THERAPEUTICS LIMITED and AVALON POLYTOM (HK) LIMITED PEGTOMARGINASELicense Agreement • July 2nd, 2018 • Athenex, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into as of June 29, 2018 (“Effective Date”), by and between ATHENEX THERAPEUTICS LIMITED, company existing under the laws of Hong Kong and having its principal office at Units 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Sha Tin, New Territories, Hong Kong (“Athenex”) and AVALON POLYTOM (HK) LIMITED, a company existing under the laws of Hong Kong and having a registered address at 10/F, Fung House, 19-20 Connaught Road Central, Hong Kong (“Avalon”).
